Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 518 participants.

Also called NCT06122974

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 518 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06122974
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06122974. Randomized; single masking; primary purpose treatment. Start 2026-08 (anticipated); primary completion 2032-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia
Acronym
DEEPER RCT
Condition
Critical Limb Ischemia
Intervention (Device)
Drug Eluting Temporary Spur Stent System
Intervention (Device)
Percutaneous Transluminal Balloon Angioplasty
Lead sponsor
ReFlow Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06122974
Content hash
e6fb810126542e00f66e146b9dc1631daf85a65d99abb7e2dca61a1bd8449ca4